Nice

News

Kadcyla finally gets OK after price cut and NICE concessions

Roche’s breast cancer drug Kadcyla is set for regular NHS funding in England after the company finally agreed a deal with NICE.

News

Amgen’s myeloma treatment Kyprolis gains NICE approval

NICE has recommended Amgen’s multiple myeloma treatment Kyprolis, a next generation drug which has shown itself superior to Janssen’s standard treatment Velcade.

News

Lilly’s sarcoma drug Lartruvo recommended via Cancer Drugs F...

Lilly's drug will be re-appraised in 2020

News

Scotland decision helps Opdivo in UK market access picture

The last 18 months has seen groundbreaking cancer immunotherapies, led by BMS’s Opdivo and Merck Sharp & Dohme’s Keytruda hit the UK market, with both rapidly adding multiple indication

News